基于关联规则的防治肝硬化腹水组方规律研究  

Study on Prescription Rules of Prevention and Treatment of Cirrhotic Ascites Based on Association Rules

作　　者：周晴 叶敏[2] Zhou Qing;Ye Min

机构地区：[1]安徽中医药大学医药信息工程学院,安徽合肥230012 [2]安徽中医药大学中医学院,安徽合肥230012

出　　处：《科教文汇》2020年第25期107-109,116,共4页Journal of Science and Education

基　　金：安徽中医药大学自然一般科研项目(2017zryb001);安徽中医药大学探索性项目(第一批)(2016ts095)。

摘　　要：目的:研究中药防治肝腹水类方的用药特点和组方规律。方法:在中国学术期刊全文数据库(CNKI)中检索肝硬化腹水中医诊证治或研究的相关文献,建立方剂数据库,采用挖掘关联规则频繁项集的Apriori算法,按照“3-5-8”的技术路线,对大量治疗肝硬化腹水的方剂进行关联规则分析。结果:得出由8味核心药物组成的实验方剂(泽泻、茯苓、白术、黄芪、猪苓、丹参、鳖甲、甘草),数据挖掘实验结果符合中医辨证论治肝硬化腹水的用药规律。Objective:To study the medication characteristics and prescription rules of traditional Chinese medicine for the prevention and treatment of liver ascites.Methods:We retrieved relevant literature on the treatment or research of cirrhotic ascites with traditional Chinese medicine on CNKI,established a prescription database,used the Apriori algorithm for mining frequent itemsets of association rules,and conducted an association rules analysis of a large number of prescriptions for the treatment of cirrhosis ascites.Results:The experimental prescription composed of 8 core medicines were obtained,including Alisma Orientalis,Poria,Atractylodes,Astragalus,Polyporus,Salvia,Turtle Shell,and Licorice,and the data mining experiment results accorded with the dialectic rule of traditional Chinese medicine for the treatment of cirrhosis ascites.

关 键 词：肝硬化腹水 关联规则 中药复方 组方规律 

分 类 号：G642[文化科学—高等教育学]